Follow The Filings

ALMS Alumis Inc.

Health Care, filed as ALUMIS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 1.4%
  • $15M
  • 1 exit

In 2026 Q2 Farallon Capital Management sold out of Alumis.

Who owns this now

Largest portfolio weights among holders, up to 1.4% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman 1.4%

Who owns ALMS

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management 1.4% Hold 550,000 $15M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 11,000 $242K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ALMS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALMS insider trades
  • $61.7M bought by 4 insiders
  • $1.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Srinivas Akkaraju Director
    Buy
    $10.7M 986,721 shares at $10.87 +75% to stake
    Traded Sep 4–8 Filed Sep 9
  2. Srinivas Akkaraju Director
    Sale
    $1M 96,131 shares at $10.55 4.5% of stake
    Traded Sep 8 Filed Sep 9
  3. Sanam Pangali Chief Legal Officer
    Sale
    $140K 5,000 shares at $28.00 31% of stake
    Traded Jul 6 Filed Jul 8
  4. Srinivas Akkaraju Director
    Buy
    $10M 588,235 shares at $17.00 +47% to stake
    Traded Jan 9 Filed Jan 13
  5. Foresite Labs, LLC 10% owner, +1 joint filer
    Buy
    $7M 411,764 shares at $17.00 +17% to stake
    Traded Jan 8 Filed Jan 12
  6. Srinivas Akkaraju Director
    Buy
    $1.8M 186,377 shares at $9.84 +17% to stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
  7. Srinivas Akkaraju Director
    Buy
    $2M 262,027 shares at $7.79 +32% to stake
    Traded Dec 2–4 Filed Dec 4, 2025
  8. Srinivas Akkaraju Director
    Buy
    $1.3M 173,589 shares at $7.55 +27% to stake
    Traded Nov 26, 2025–Dec 1, 2025 Filed Dec 1, 2025
  9. Foresite Capital Management VI LLC 10% owner, +8 joint filers
    Buy
    $533K 72,212 shares at $7.38 +2.8% to stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
  10. Srinivas Akkaraju Director
    Buy
    $905K 125,743 shares at $7.20 +24% to stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  11. Srinivas Akkaraju Director
    Buy
    $1.5M 241,338 shares at $6.34 +87% to stake
    Traded Nov 17–19 Filed Nov 19, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 other transactions, 6 sales to cover taxes, 5 stock grants, and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 8.01,9.01
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13D/A —
8-K 5.07
8-K 8.01,9.01
DEF 14A
DEFA14A
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13D/A —
8-K 8.01,9.01
8-K 2.02,9.01
10-K

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue — $24.05M
Net income -$294.23M -$243.32M
Net margin * — -1011.7%

Balance sheet

Metric FY2024 FY2025
Total current assets $306.19M $318.23M
Total non-current assets * $34.8M $93.71M
Total assets $340.99M $411.94M
Total current liabilities $50.91M $73.32M
Total non-current liabilities * $29.98M $37.32M
Total equity $260.1M $301.3M

Cash flow

Metric FY2024 FY2025
Cash from operations -$255.08M -$369.52M
Cash from investing -$113.79M $287.88M
Cash from financing $492.37M $2.07M
Net change in cash * $123.5M -$79.58M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.